CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

Abbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD ...

Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India, benefiting millions with Type 2 ...

Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...

Abbott and MSD Pharmaceuticals announced a distribution pact for oral anti-diabetic medicines like Januvia, Janumet, and ...

Abbott and MSD Pharmaceuticals announced a partnership to distribute oral anti-diabetic medicines, specifically sitagliptin, ...

Abbott & MSD ink strategic pact to distribute innovative oral anti-diabetic medicines in India: Our Bureau, Bengaluru Thursday, June 19, 2025, 12:30 Hrs [IST] Abbott and MSD Pharm ...

Abbott partners with MSD to distribute leading diabetes medications in India, enhancing patient access and care.

Sitagliptin has played a crucial role in managing type 2 diabetes by lowering HbA1c levels and improving blood sugar control.

Under the terms of the partnership, Abbott will utilise its distribution infrastructure to promote MSD’s sitagliptin-based ...

Blood circulation problems common in seniors with diabetes affect how medications reach their target tissues. Poor circulation to the digestive system can reduce oral medication absorption ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data ...